Honasa Consumer Limited · NSE:HONASA

Honasa Consumer — Merger or Acquisition

7 slides from Honasa Consumer's merger presentation

  1. Slide 1: Acquisition Announcement - Investor Communication

    STRICTLY PRIVATE AND CONFIDENTIAL Acquisition Announcement Q2 & H1 FY25 Q1FY25 Q4 & FY24 Results Investor Communication Q2 & H1 FY24

  2. Slide 2: Nutraceuticals - a category at a cusp of inflection

    Nutraceuticals - a category at a cusp of inflection Last decade: Actives. Next decade: Actives + Nutraceuticals - as consumers demand inside-out solutions that address the root cause ~40% INR 16K Cr+ 80%+ Growth in Searches for Hair Care and Skin Size of Vitamins, Minerals and Supplements Affluent c

  3. Slide 3: Honasa Consumer Limited enters Nutraceuticals with the acquisition of Fluence Pharma

    Honasa Consumer Limited Enters Nutraceuticals with the Acquisition of 1 Powered by Patented Cyclical Nutrition Therapy* *Cyclical Nutrition Therapy include OTC supplements administered in a structured sequence to maximize efficacy Refers to Fluence Pharma Private Limited 3

  4. Slide 4: Fluence Pharma – a differentiated and patented science led nutraceuticals play

    Fluence Pharma – a differentiated and patented science led nutraceuticals play Offers condition-specific OTC supplement kits sold exclusively through dermatologists - built on patented Cyclical Nutritional Therapy Patented & Doctor Network Moat with In-Clinic Solutions for Hair are the Differentiate

  5. Slide 5: The acquisition will enable Honasa's foray into building a B2C franchise in nutraceuticals

    The acquisition will enable Honasa’s foray into building a B2C franchise in nutraceuticals Building trust and evidence led nutraceutical regimes anchored in Fluence's patented science through Honasa Health1 Honasa Health to build Topical plus nutraceutical regimes for hair fall, acne and A trust and

  6. Slide 6: Creating a seasoned team to build nutraceuticals into a INR 500 Cr franchise

    With this acquisition, Honasa is creating a seasoned team to build nutraceuticals into a INR 500 Cr franchise Fluence Pharma Honasa Health2 Mr. Amit Bhusari Dr. Rajendra Singh Rajput Mr. Dheeraj Nagpal Inventor of CNT1 and CEO & Co-Founder, Fluence Pharma CEO, Honasa Health2 Co-Founder, Fluence Phar

  7. Slide 7: Key Terms of the Transaction

    Key Terms of the Transaction Tranche 1 58% ~₹135 Cr ~3.4x ~15x Stake Acquired Enterprise Value EV / FY26 Revenue¹ EV / FY26 EBITDA¹ Secondary purchase, Tranche 1 Subject to closing adjustments Implied multiple Implied multiple Tranche 2 and 3 To be closed in the Next 5–7 Years Remaining stake to be

Honasa Consumer — Merger or Acquisition on 6ix